- Home
- OM
as 06-20-2025 3:39pm EST
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 305.5M | IPO Year: | 2020 |
| Target Price: | $33.00 | AVG Volume (30 days): | 288.3K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -26.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.85 - $72.60 | Next Earning Date: | 08-06-2025 |
| Revenue: | $115,273,000 | Revenue Growth: | -7.84% |
| Revenue Growth (this year): | 10.8% | Revenue Growth (next year): | 11.99% |
Stock Insider Trading Activity of Outset Medical Inc. (OM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nash Marc | OM | SVP Operations and R&D | May 15 '25 | Sell | $17.82 | 252 | $4,490.64 | 13,465 | |
| Ahmed Nabeel | OM | Chief Financial Officer | May 15 '25 | Sell | $17.81 | 584 | $10,401.04 | 16,096 | |
| Trigg Leslie | OM | Chair and CEO | May 15 '25 | Sell | $17.80 | 935 | $16,643.00 | 58,129 | |
| Brottem John L. | OM | General Counsel | May 15 '25 | Sell | $17.82 | 396 | $7,056.72 | 11,273 |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
MT Newswires
17 days ago
TD Cowen Adjusts Price Target on Outset Medical to $25 From $15, Maintains Buy Rating
MT Newswires
17 days ago
Outset Medical Names Renee Gaeta as CFO
GlobeNewswire
18 days ago
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
MT Newswires
a month ago
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating
GlobeNewswire
a month ago
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
Simply Wall St.
a month ago
Outset Medical First Quarter 2025 Earnings: Beats Expectations
GlobeNewswire
a month ago
Outset Medical to Present at RBC Global Healthcare Conference
Compare OM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.